Oncoheroes is a ground-breaking biotech company exclusively focused on the discovery and development of better drugs for children and adolescents with cancer. The company is headquartered in Boston, US, with a discovery lab in Barcelona, Spain. Oncoheroes is working to generate new proprietary assets for a number of pediatric cancer indications with a high unmet medical need.
One of Oncoheroes’ strengths is the professional trajectory and commitment of the founders, two of them fathers of children who suffered cancer, and the rest of the team, with most members having more than 20 years of experience in drug development. In addition to that, we are proud of our Scientific Advisory Board, formed by world leaders in pediatric oncology, as well as the relationships already established with the main institutions and organizations of childhood cancer worldwide (e.g. ITCC (Europe), Children Oncology Group (US)).
Oncoheroes is working to generate new proprietary assets for a number of pediatric cancer indications with a high unmet medical need.
Due to insufficient specific therapies for children with cancer, pediatric oncologists are forced to adjust adult cancer treatments for childhood cancer. Only 4 treatments designed specifically for pediatric cancer have been approved by the FDA vs. more than 200 for adults. Oncoheroes is 100% focused on childhood cancer with a highly specialized team, network, and resources to bring new drugs developed for children.
Childhood cancer community